Fedele E
Int J Mol Sci. 2023; 24(19).
PMID: 37833948
PMC: 10578107.
DOI: 10.3390/ijms241914499.
Ramamurthy E, Welch G, Cheng J, Yuan Y, Gunsalus L, Bennett D
Front Mol Neurosci. 2023; 15:948456.
PMID: 36683855
PMC: 9853565.
DOI: 10.3389/fnmol.2022.948456.
Nguyen P, Ramamoorthy A, Sahoo B, Zheng J, Faller P, Straub J
Chem Rev. 2021; 121(4):2545-2647.
PMID: 33543942
PMC: 8836097.
DOI: 10.1021/acs.chemrev.0c01122.
Liu S, Zhao Y, Su X, Zhou C, Yang P, Lin Q
Stem Cells Int. 2020; 2020:8897494.
PMID: 33381193
PMC: 7762651.
DOI: 10.1155/2020/8897494.
Dar N, Glazner G
Cell Mol Life Sci. 2020; 77(12):2315-2330.
PMID: 31960113
PMC: 11105086.
DOI: 10.1007/s00018-019-03404-x.
The vexing complexity of the amyloidogenic pathway.
Castro M, Hadziselimovic A, Sanders C
Protein Sci. 2019; 28(7):1177-1193.
PMID: 30897251
PMC: 6566549.
DOI: 10.1002/pro.3606.
Alzheimer's disease in Down syndrome: An overlooked population for prevention trials.
Strydom A, Coppus A, Blesa R, Danek A, Fortea J, Hardy J
Alzheimers Dement (N Y). 2018; 4:703-713.
PMID: 30581976
PMC: 6296162.
DOI: 10.1016/j.trci.2018.10.006.
Amyloid precursor protein in pancreatic islets.
Kulas J, Puig K, Combs C
J Endocrinol. 2017; 235(1):49-67.
PMID: 28710249
PMC: 6267436.
DOI: 10.1530/JOE-17-0122.
Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments.
Castro P, Zaman S, Holland A
J Neurol. 2016; 264(4):804-813.
PMID: 27778163
PMC: 5374178.
DOI: 10.1007/s00415-016-8308-8.
Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.
Raja W, Mungenast A, Lin Y, Ko T, Abdurrob F, Seo J
PLoS One. 2016; 11(9):e0161969.
PMID: 27622770
PMC: 5021368.
DOI: 10.1371/journal.pone.0161969.
Monoaminergic neuropathology in Alzheimer's disease.
Simic G, Babic Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milosevic N
Prog Neurobiol. 2016; 151:101-138.
PMID: 27084356
PMC: 5061605.
DOI: 10.1016/j.pneurobio.2016.04.001.
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.
Simic G, Babic Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milosevic N
Biomolecules. 2016; 6(1):6.
PMID: 26751493
PMC: 4808800.
DOI: 10.3390/biom6010006.
Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
Mungenast A, Siegert S, Tsai L
Mol Cell Neurosci. 2015; 73:13-31.
PMID: 26657644
PMC: 5930170.
DOI: 10.1016/j.mcn.2015.11.010.
The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.
Zhou Z, Chan C, Ma Q, Xu X, Xiao Z, Tan E
Cell Adh Migr. 2011; 5(4):280-92.
PMID: 21785276
PMC: 3210295.
DOI: 10.4161/cam.5.4.16986.
Targets for AD treatment: conflicting messages from γ-secretase inhibitors.
Sambamurti K, Greig N, Utsuki T, Barnwell E, Sharma E, Mazell C
J Neurochem. 2011; 117(3):359-74.
PMID: 21320126
PMC: 3076515.
DOI: 10.1111/j.1471-4159.2011.07213.x.